TABLE 4

Summary pharmacokinetic parameters determined by noncompartmental analysis of total drug concentrations of OMI in WT, BKO, PKO, and TKO FVB mice after a single intravenous dose (5 mg/kg) and after coadministration with loperamide (5 mg/kg)

A two-tailed unpaired t test was performed to compare AUCs among tissues within the same study (see results) and between the same tissues in discrete vs. combination studies. A one-way ANOVA with Tukey’s multiple comparisons test was used to compare AUCs for the same tissue among different genotypes. Results are presented as mean or mean ± S.D.

DrugParameterWild-TypeBKOPKOTKO
OMI alonet1/2 (h)2.92.92.62.8
CL (l/h)/kg9.88.06.77.4
V (l/kg)24.916.615.515.5
AUC0→∞ or (last) Plasma (h*ng)/ml508 ± 57623 ± 86735 ± 43670 ± 42
AUC0→∞ or (last)
Brain (h*ng)/g
500 ± 116760 ± 665976 ± 1845665 ± 159
AUC0→∞ or (last) Spinal Cord (h*ng)/g172 ± 16121 ± 275689 ± 6072952 ± 62
KpBrain1.01.28.18.4
KpSpinal cord0.340.187.64.3
OMI in combinationt1/2 (h)2.52.63.483.37
CL (l/h)/kg5.03.01.82.6
V (l/kg)138.75.810.1
AUC0→∞ or (last) Plasma (h*ng)/ml1002 ± 1671541 ± 2452613 ± 2581893 ± 130
AUC0→∞ or (last)
Brain (h*ng)/g
1115 ± 1361076 ± 776993 ± 5817128 ± 458
AUC0→∞ or (last) Spinal Cord (h*ng)/g326 ± 71248 ± 323584 ± 2603913 ± 203
KpBrain1.10.712.73.7
KpSpinal cord0.330.161.372.0